The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world trends of PARPi maintenance treatment uptake and progression-free survival (PFS) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in the United States.
 
John K Chan
Consulting or Advisory Role - Abbvie; Acerta Pharma; Aravive; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Merck
Speakers' Bureau - Abbvie; Acerta Pharma; Aravive; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Merck
Research Funding - Abbvie; Acerta Pharma; Aravive; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Merck
 
Jinan Liu
Employment - GlaxoSmithKline
 
Jinlin Song
Employment - Analysis Group
Research Funding - GlaxoSmithKline
 
Cheryl Xiang
Employment - Analysis Group
Research Funding - GlaxoSmithKline
 
Eric Q. Wu
Employment - Analysis Group
Research Funding - GlaxoSmithKline
 
Linda Kalilani
Employment - GlaxoSmithKline
 
Jean Hurteau
Employment - DuPage Medical Group (I); GlaxoSmithKline
Stock and Other Ownership Interests - DuPage Medical Group (I); GlaxoSmithKline
 
Premal H. Thaker
Stock and Other Ownership Interests - Celsion
Consulting or Advisory Role - AstraZeneca; Celsion; Eisai; GlaxoSmithKline; Immunogen; Iovance Biotherapeutics; Merck; Novocure; Seagen
Research Funding - GlaxoSmithKline (Inst); Merck (Inst)